VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | Agents of interest being explored in essential thrombocythemia and polycythemia vera

Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, highlights novel agents of interest being explored for the treatment of polycythemia vera (PV) and essential thrombocythemia (ET), including rusfertide and bomedemstat. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Disclosures

Advisory boards for Novartis, Abbvie, BMS, AOP Orphan.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter